Stonepine Capital Management as of June 30, 2018
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 25 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| BioSpecifics Technologies | 12.6 | $21M | 461k | 44.86 | |
| Cti Biopharma | 12.2 | $20M | 4.0M | 4.98 | |
| Apollo Endosurgery | 10.9 | $18M | 2.6M | 6.98 | |
| Amarin Corporation | 10.7 | $18M | 5.7M | 3.09 | |
| Vanda Pharmaceuticals (VNDA) | 6.9 | $11M | 600k | 19.05 | |
| Viveve Med | 6.4 | $11M | 3.8M | 2.72 | |
| Cumberland Pharmaceuticals (CPIX) | 4.5 | $7.4M | 1.2M | 6.13 | |
| Correvio Pharma Corp | 4.4 | $7.3M | 1.9M | 3.78 | |
| Alimera Sciences | 4.2 | $6.8M | 7.0M | 0.98 | |
| Noveliontherapeuti.. | 4.0 | $6.6M | 1.8M | 3.68 | |
| Htg Molecular Diagnostics | 3.4 | $5.5M | 1.7M | 3.26 | |
| Ophthotech | 3.2 | $5.2M | 1.9M | 2.73 | |
| BioDelivery Sciences International | 2.7 | $4.4M | 1.5M | 2.95 | |
| Rigel Pharmaceuticals | 2.6 | $4.2M | 1.5M | 2.83 | |
| Adma Biologics (ADMA) | 2.3 | $3.8M | 832k | 4.51 | |
| ACADIA Pharmaceuticals (ACAD) | 1.8 | $3.0M | 195k | 15.27 | |
| Alphatec Holdings (ATEC) | 1.6 | $2.7M | 903k | 2.98 | |
| Catabasis Pharmaceuticals | 1.4 | $2.3M | 2.4M | 0.96 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.3 | $2.2M | 426k | 5.20 | |
| Syndax Pharmaceuticals (SNDX) | 0.8 | $1.4M | 198k | 7.02 | |
| Cancer Genetics | 0.8 | $1.2M | 1.4M | 0.89 | |
| Gemphire Therapeutics | 0.6 | $1.0M | 103k | 10.19 | |
| Conformis | 0.5 | $770k | 616k | 1.25 | |
| Melinta Therapeutics | 0.2 | $331k | 52k | 6.34 | |
| Invivo Therapeutics Hldgs Corp | 0.1 | $132k | 78k | 1.69 |
